The global progenitor cell product market is expected to grow at a CAGR of 8.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for stem cells in medical care and hospital applications. The global progenitor cell product market is segmented on the basis of type, application, and region. On the basis of type, it is segmented into pancreatic progenitor cells (PPCs), cardiac progenitor cells (CPCs), intermediate progenitor cells (IPCs), neural progenitors (NPCs), and endothelial progenitors (EPCs). On the basis of application, it is segmented into medical care and hospital applications. Medical care includes regenerative medicine therapies such as bone marrow transplantation or hematopoietic stem cell transplantation; while hospital includes treatments such as chemotherapy or radiation therapy for cancer patients. On the basis of region, it is segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa regions.
- The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is driving the growth of the Progenitor Cell Product market.
- Increasing awareness about stem cell therapy and regenerative medicine among patients is also driving the growth of the Progenitor Cell Product market.
- Increasing research and development activities in this field are also contributing to the growth of this market.
Industry Growth Insights published a new data on “Progenitor Cell Product Market”. The research report is titled “Progenitor Cell Product Market research by Types (Pancreatic progenitor cells, Cardiac Progenitor Cells, Intermediate progenitor cells, Neural progenitor cells (NPCs), Endothelial progenitor cells (EPC), Others), By Applications (Medical care, Hospital, Laboratory), By Players/Companies NeuroNova AB, StemCells, ReNeuron Limited, Asterias Biotherapeutics, Thermo Fisher Scientific, STEMCELL Technologies, Axol Bio, R&D Systems, Lonza, ATCC, Irvine Scientific, CDI”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Progenitor Cell Product Market Research Report
By Type
Pancreatic progenitor cells, Cardiac Progenitor Cells, Intermediate progenitor cells, Neural progenitor cells (NPCs), Endothelial progenitor cells (EPC), Others
By Application
Medical care, Hospital, Laboratory
By Companies
NeuroNova AB, StemCells, ReNeuron Limited, Asterias Biotherapeutics, Thermo Fisher Scientific, STEMCELL Technologies, Axol Bio, R&D Systems, Lonza, ATCC, Irvine Scientific, CDI
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Progenitor Cell Product Market Report Segments:
The global Progenitor Cell Product market is segmented on the basis of:
Types
Pancreatic progenitor cells, Cardiac Progenitor Cells, Intermediate progenitor cells, Neural progenitor cells (NPCs), Endothelial progenitor cells (EPC), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical care, Hospital, Laboratory
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- NeuroNova AB
- StemCells
- ReNeuron Limited
- Asterias Biotherapeutics
- Thermo Fisher Scientific
- STEMCELL Technologies
- Axol Bio
- R&D Systems
- Lonza
- ATCC
- Irvine Scientific
- CDI
Highlights of The Progenitor Cell Product Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pancreatic progenitor cells
- Cardiac Progenitor Cells
- Intermediate progenitor cells
- Neural progenitor cells (NPCs)
- Endothelial progenitor cells (EPC)
- Others
- By Application:
- Medical care
- Hospital
- Laboratory
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Progenitor Cell Product Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Progenitor Cell is a dietary supplement that claims to help improve the health of cells in the body. The product is made from natural ingredients and is supposed to support healthy cell growth.
Some of the major companies in the progenitor cell product market are NeuroNova AB, StemCells, ReNeuron Limited, Asterias Biotherapeutics, Thermo Fisher Scientific, STEMCELL Technologies, Axol Bio, R&D Systems, Lonza, ATCC, Irvine Scientific, CDI.
The progenitor cell product market is expected to register a CAGR of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Progenitor Cell Product Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Progenitor Cell Product Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Progenitor Cell Product Market - Supply Chain
4.5. Global Progenitor Cell Product Market Forecast
4.5.1. Progenitor Cell Product Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Progenitor Cell Product Market Size (000 Units) and Y-o-Y Growth
4.5.3. Progenitor Cell Product Market Absolute $ Opportunity
5. Global Progenitor Cell Product Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Progenitor Cell Product Market Size and Volume Forecast by Type
5.3.1. Pancreatic progenitor cells
5.3.2. Cardiac Progenitor Cells
5.3.3. Intermediate progenitor cells
5.3.4. Neural progenitor cells (NPCs)
5.3.5. Endothelial progenitor cells (EPC)
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Progenitor Cell Product Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Progenitor Cell Product Market Size and Volume Forecast by Application
6.3.1. Medical care
6.3.2. Hospital
6.3.3. Laboratory
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Progenitor Cell Product Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Progenitor Cell Product Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Progenitor Cell Product Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Progenitor Cell Product Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Progenitor Cell Product Demand Share Forecast, 2019-2026
9. North America Progenitor Cell Product Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Progenitor Cell Product Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Progenitor Cell Product Market Size and Volume Forecast by Application
9.4.1. Medical care
9.4.2. Hospital
9.4.3. Laboratory
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Progenitor Cell Product Market Size and Volume Forecast by Type
9.7.1. Pancreatic progenitor cells
9.7.2. Cardiac Progenitor Cells
9.7.3. Intermediate progenitor cells
9.7.4. Neural progenitor cells (NPCs)
9.7.5. Endothelial progenitor cells (EPC)
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Progenitor Cell Product Demand Share Forecast, 2019-2026
10. Latin America Progenitor Cell Product Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Progenitor Cell Product Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Progenitor Cell Product Market Size and Volume Forecast by Application
10.4.1. Medical care
10.4.2. Hospital
10.4.3. Laboratory
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Progenitor Cell Product Market Size and Volume Forecast by Type
10.7.1. Pancreatic progenitor cells
10.7.2. Cardiac Progenitor Cells
10.7.3. Intermediate progenitor cells
10.7.4. Neural progenitor cells (NPCs)
10.7.5. Endothelial progenitor cells (EPC)
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Progenitor Cell Product Demand Share Forecast, 2019-2026
11. Europe Progenitor Cell Product Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Progenitor Cell Product Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Progenitor Cell Product Market Size and Volume Forecast by Application
11.4.1. Medical care
11.4.2. Hospital
11.4.3. Laboratory
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Progenitor Cell Product Market Size and Volume Forecast by Type
11.7.1. Pancreatic progenitor cells
11.7.2. Cardiac Progenitor Cells
11.7.3. Intermediate progenitor cells
11.7.4. Neural progenitor cells (NPCs)
11.7.5. Endothelial progenitor cells (EPC)
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Progenitor Cell Product Demand Share, 2019-2026
12. Asia Pacific Progenitor Cell Product Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Progenitor Cell Product Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Progenitor Cell Product Market Size and Volume Forecast by Application
12.4.1. Medical care
12.4.2. Hospital
12.4.3. Laboratory
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Progenitor Cell Product Market Size and Volume Forecast by Type
12.7.1. Pancreatic progenitor cells
12.7.2. Cardiac Progenitor Cells
12.7.3. Intermediate progenitor cells
12.7.4. Neural progenitor cells (NPCs)
12.7.5. Endothelial progenitor cells (EPC)
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Progenitor Cell Product Demand Share, 2019-2026
13. Middle East & Africa Progenitor Cell Product Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Progenitor Cell Product Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Progenitor Cell Product Market Size and Volume Forecast by Application
13.4.1. Medical care
13.4.2. Hospital
13.4.3. Laboratory
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Progenitor Cell Product Market Size and Volume Forecast by Type
13.7.1. Pancreatic progenitor cells
13.7.2. Cardiac Progenitor Cells
13.7.3. Intermediate progenitor cells
13.7.4. Neural progenitor cells (NPCs)
13.7.5. Endothelial progenitor cells (EPC)
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Progenitor Cell Product Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Progenitor Cell Product Market: Market Share Analysis
14.2. Progenitor Cell Product Distributors and Customers
14.3. Progenitor Cell Product Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. NeuroNova AB
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. StemCells
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. ReNeuron Limited
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Asterias Biotherapeutics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Thermo Fisher Scientific
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. STEMCELL Technologies
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Axol Bio
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. R&D Systems
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Lonza
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. ATCC
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Irvine Scientific
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. CDI
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
